Efficacy and Safety of TDF+3TC+EFV in Adults With HIV/HBV Coinfection
Status:
Completed
Trial end date:
2013-06-01
Target enrollment:
Participant gender:
Summary
This is a Phase 4 single-arm, post-marketing clinical trial evaluating the efficacy and
safety of tenofovir disoproxil fumarate, lamivudine and efavirenz in adults with human
immunodeficiency virus-1 and hepatitis B virus coinfection.
Phase:
Phase 4
Details
Lead Sponsor:
National Center for AIDS/STD Control and Prevention, China CDC